Abstract
Alzheimer's disease (AD) is a neurodegenerative disease characterized by a low acetylcholine (ACh) concentration in the hippocampus and cortex. ACh is a neurotransmitter hydrolyzed by acetylcholinesterase (AChE). Therefore, it is not surprising that AChE inhibitors (AChEIs) have shown better results in the treatment of AD than any other strategy. To improve the effects of AD, many researchers have focused on designing and testing new AChEIs. One of the principal strategies has been the use of computational methods (structural bioinformatics or in silico methods).
In this review, we summarize the in silico methods used to enhance the understanding of AChE, particularly at the binding site, to design new AChEIs. Several computational methods have been used, such as docking approaches, molecular dynamics studies, quantum mechanical studies, electronic properties, hindrance effects, partition coefficients (Log P) and molecular electrostatic potentials surfaces, among other physicochemical methods that exhibit quantitative structure-activity relationships.
Keywords: In silico methods, docking, acetylcholinesterase, molecular dynamics, sequence alignment, Alzheimer's disease, AChEIs, hindrance effects, SAR, Protein Data Bank
Current Medicinal Chemistry
Title: In Silico Methods to Assist Drug Developers in Acetylcholinesterase Inhibitor Design
Volume: 18 Issue: 8
Author(s): J. A. Bermudez-Lugo, M. C. Rosales-Hernandez, O. Deeb, J. Trujillo-Ferrara and J. Correa-Basurto
Affiliation:
Keywords: In silico methods, docking, acetylcholinesterase, molecular dynamics, sequence alignment, Alzheimer's disease, AChEIs, hindrance effects, SAR, Protein Data Bank
Abstract: Alzheimer's disease (AD) is a neurodegenerative disease characterized by a low acetylcholine (ACh) concentration in the hippocampus and cortex. ACh is a neurotransmitter hydrolyzed by acetylcholinesterase (AChE). Therefore, it is not surprising that AChE inhibitors (AChEIs) have shown better results in the treatment of AD than any other strategy. To improve the effects of AD, many researchers have focused on designing and testing new AChEIs. One of the principal strategies has been the use of computational methods (structural bioinformatics or in silico methods).
In this review, we summarize the in silico methods used to enhance the understanding of AChE, particularly at the binding site, to design new AChEIs. Several computational methods have been used, such as docking approaches, molecular dynamics studies, quantum mechanical studies, electronic properties, hindrance effects, partition coefficients (Log P) and molecular electrostatic potentials surfaces, among other physicochemical methods that exhibit quantitative structure-activity relationships.
Export Options
About this article
Cite this article as:
A. Bermudez-Lugo J., C. Rosales-Hernandez M., Deeb O., Trujillo-Ferrara J. and Correa-Basurto J., In Silico Methods to Assist Drug Developers in Acetylcholinesterase Inhibitor Design, Current Medicinal Chemistry 2011; 18 (8) . https://dx.doi.org/10.2174/092986711795029681
DOI https://dx.doi.org/10.2174/092986711795029681 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Beneficial Effects of Sulfur-containing Amino Acids on Cisplatininduced Cardiotoxicity and Neurotoxicity in Rodents
Current Medicinal Chemistry Genistein Decreases APP/tau Phosphorylation and Ameliorates Aβ Overproduction Through Inhibiting CIP2A
Current Alzheimer Research Human Milk has Anti-Oxidant Properties to Protect Premature Infants
Current Pediatric Reviews Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity
Current Medicinal Chemistry The Mitochondrial Thioredoxin is Required for Liver Development in Zebrafish
Current Molecular Medicine Risk Factors for Suicidal Ideation Among High School Students in Istanbul
Adolescent Psychiatry A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials
Current Drug Targets Molecular Biomarkers for Lung Adenocarcinoma: A Short Review
Current Cancer Therapy Reviews Does an Interdisciplinary Network Improve Dementia Care? Results from the IDemUck-Study
Current Alzheimer Research Transcriptional Regulation of Cytochrome P450 2B Genes by Nuclear Receptors
Current Drug Metabolism Management of Obesity in Patients with Type 2 Diabetes Mellitus
Current Diabetes Reviews The Inhibitory Effect of Panax Ginseng Extract on Amyloid-like Fibril Formation of Trypsin in Aqueous Ethanol
Protein & Peptide Letters UDP-Glucuronosyltransferases
Current Drug Metabolism Inflammasome Activation in Chronic Glomerular Diseases
Current Drug Targets Candidate Biomarkers for Fatigue in Systemic Lupus Erythematosus: A Critical Review
Current Rheumatology Reviews Rituximab Therapy and Autoimmune Disease
Current Immunology Reviews (Discontinued) Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition
Current Neuropharmacology Oxidative Stress in the Pathogenesis/Treatment of Diabetes and its Complications
Current Nutrition & Food Science Endocannabinoids in Neuroimmunology and Stress
Current Drug Targets - CNS & Neurological Disorders Therapy in Prion Diseases
Current Topics in Medicinal Chemistry